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Introduction
Alternative splicing is a process that alters the coding capacity 
of genomes (Sultan et al., 2008; Wang et al., 2008), and it thus 
occupies a unique place in the control of gene expression (for 
review see Blencowe, 2006). Splicing is a two-step chemical 
reaction performed by the spliceosome, a complex RNP ma-
chine that assembles anew on every intron (for review see Wahl 
et al., 2009). It is composed of five RNAs and about a hundred 
proteins, and in vitro studies have defined an ordered assembly 
pathway. First, U1 small nuclear RNA (snRNA) binds the   
5 splice site, whereas the branch point, poly-pyrimidine tract, 
and 3 splice site are recognized by SF1, U2AF65, and U2AF35, 
respectively. U2 snRNP is then loaded in an ATP-dependent 
step to form the A complex. The U4/U5/U6 tri-snRNP further 
joins to form the B complex, which loses U1 and U4 and undergoes 
remodeling  to  become  competent  for  catalysis. After  the  first 
trans-esterification reaction, the composition of the spliceosome 
is again modified, yielding the C complex that performs the 
second trans-esterification. Finally, post-spliceosomes are dis-
assembled, their components recycled and introns are degraded.
In vivo, splicing is intimately connected with transcription 
(for review see Pandit et al., 2008). Studies on a few mRNAs 
have shown that splicing can occur cotranscriptionally (Beyer 
and Osheim, 1988; Baurén and Wieslander, 1994; Kiseleva   
et al., 1994; Zhang et al., 1994; Pandya-Jones and Black 2009;   
de la Mata et al., 2010). However, recent studies in yeast have 
indicated that the relative kinetics of splicing versus transcrip-
tion determine whether an intron splices cotranscriptionally or 
not (Tardiff et al., 2006; Carrillo-Oesterreich et al., 2010). We 
currently lack a genome-wide view of co- and posttranscrip-
tional splicing in higher eukaryotes. However, there are many 
links between splicing and transcription. First, the RNA poly-
merase II recruits splicing factors to promote cotranscriptional 
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Figure 1.  Co-transcriptional splicing and characterization of the MINX reporter cell lines. (A) RT-PCR assay to determine whether introns splice cotranscrip-
tionally or not. A hypothetical gene is schematized with the position of the primers used for RT and the competitive PCR. (B) Scheme of the MINX constructs. 
SAmut_MS2in contains a single AG to GG mutation at the splice acceptor site. The green, red, and blue bars represent the positions of the FISH probes, 821 In vivo splicing kinetics • Schmidt et al.
and the distance is indicated in nucleotides. (C) RNA polymerase II accumulates at the reporter transcription site. WT_MS2in stable cells were transfected 
with Tat and processed for in situ hybridization with an MS2 probe (red), and for immunofluorescence against the large subunit of RNA polymerase II (RPB1, 
green). Insets show enlarged images. Bar, 10 µm. (D) WT_MS2in is spliced cotranscriptionally. WT_MS2in or SAmut_MS2in cells were treated with SSA 
when indicated, and processed for in situ hybridization with probes recognizing the intron (MS2, red), exon 2 (LacZ, blue), or the spliced junction (spliced, 
green). Bar, 10 µm. Right panels show intensity line scans of the images, using the lines defined by the arrowheads. (E) Quantification of cotranscriptional 
splicing by RT-PCR. The indicated cell lines were treated as in D, and total RNAs were extracted and RT-PCR amplified with the indicated primers (see 
scheme, the scissors depict the 3 end cleavage site). The position of the primers used for reverse transcription are also indicated. pdT, oligo dT primer;   
3 uncleaved primer, primer located downstream the polyadenylation site. Spliced RNAs: 317 bp; unspliced RNAs: 671 bp.
 
splicing (Kim et al., 1997; McCracken et al., 1997). Second, 
transcription  elongation  rates  have  been  shown  to  regulate 
alternative splicing (Roberts et al., 1998). Indeed, pause sites 
or slowing down RNA polymerase II delay the synthesis of   
competing splice sites and provide a kinetic way to regulate alter-
native splicing (de la Mata et al., 2003). For instance, when 
cells are exposed to UV light, RNA polymerase II becomes 
hyperphosphorylated, and its elongation rate decreases to in-
duce global changes in alternative splicing (Muñoz et al., 2009). 
Understanding this regulation requires the kinetic characteriza-
tion of splicing and transcription. In particular, the time taken 
to splice a single pre-mRNA should match the elongation rate 
of the polymerase that transcribes it, and the stochasticity of 
single  splicing  events  is  expected  to  reduce  regulation  effi-
ciency. However, splicing kinetics have not been characterized 
in detail, mainly because current methods do not provide a high 
temporal resolution.
Here, we have created a reporter gene that splices cotrans-
criptionally and can be monitored in real time and in live cells. 
We provide a detailed kinetic analysis of splicing in vivo, and 
propose a model that explains how the variability in splicing 
time, which we refer to as kinetic noise, is reduced to over-
ride the stochasticity of single splicing events, thereby im-
proving splicing regulation.
Results and discussion
Cotranscriptional splicing is frequent  
in human cells
Although cotranscriptional splicing has been demonstrated in 
human cells, it is not clear whether this is a predominant mode 
of splicing or not. To address this question, we chose a set of 
40  constitutive  and  alternatively  spliced  human  introns  and 
determined with a quantitative assay whether they splice co-
transcriptionally or not. To detect nascent RNAs still attached to 
chromatin, we used an RT primer situated beyond the 3 cleav-
age and polyadenylation site. Then, we performed competitive 
RT-PCR assays with primers that amplified simultaneously the 
spliced and the unspliced RNAs for the last two introns of the 
selected genes (Fig. 1 A). Because the distance the reverse tran-
scription can extend is limited, we selected introns that were 
<3 kb from the cleavage and polyadenylation site. Remarkably, 
most introns were spliced completely or nearly completely be-
fore 3 end maturation (Table I). This was also the case for four 
large introns (>1 kb) and for introns that showed alternative 
splicing. Only one intron was found to splice predominantly 
posttranscriptionally. Although this set of introns is small and 
biased for short introns, these data nevertheless suggest that 
cotranscriptional splicing is frequent in human cells. We thus 
developed a model system that splices cotranscriptionally and 
that can be monitored in living cells.
A reporter system to analyze splicing  
in live cells and in real time
We and others have previously analyzed mRNA biogenesis in 
real time, using MS2-tagged constructs integrated in the genome 
of mammalian cells and an MS2–GFP fusion protein (Fusco et al., 
2003; Boireau et al., 2007; Darzacq et al., 2007). In this set-
ting, the transcription site of the reporter gene is visible as a 
bright spot in the nucleoplasm and it is possible to measure the   
kinetics of transcription and 3 end processing by photobleach-
ing the MS2–GFP protein bound to nascent mRNAs (Boireau   
et al., 2007; Darzacq et al., 2007). Here, we introduced the 
MS2 binding sites within the MINX intron to monitor the splic-
ing reaction (reporter WT_MS2in, Fig. 1 B). This small intron 
derives from the adenovirus genome and possesses strong splic-
ing signals (Zillmann et al., 1988). We used only four MS2 
binding sites instead of 24 to minimize possible perturbations. 
To increase the chances that splicing occurs cotranscriptionally, 
we placed the tagged intron upstream of the LacZ gene (3 kb 
long), and we used the cleavage and polyadenylation sequence 
of the bovine growth hormone gene (bGH), which is processed 
at a slow rate (0.2 min
1, as opposed to 1 min
1 for the HIV-1 
polyA signals; Boireau et al., 2007). Transcription was driven 
by the HIV-1 LTR and was induced by transfecting a Tat ex-
pression vector.
To  compare  the  residency  time  of  the  intron  with  the 
one of the nascent mRNAs, we derived two other constructs 
(Fig. 1 B). In the first, the MS2 sites were inserted in exon 2 
(WT_MS2ex2).  In  the  second,  we  inhibited  splicing  with  a 
point  mutation  in  the  splice  acceptor  sequence  (AG→GG, 
SAmut_MS2in).
The MS2-tagged MINX intron  
splices cotranscriptionally
The various reporters were transfected into U2OS cells, and 
stable clones were selected and characterized. These clones con-
tained 18–20 copies of the reporter gene, and we first used 
fluorescent oligonucleotide probes to test whether splicing of 
the MS2-tagged MINX intron occurs at its transcription site. 
Three probe sets were used (Fig. 1 B). One hybridized to the 
intronic MS2 sites, one was specific for the spliced mRNA, and 
one hybridized at the beginning of the LacZ gene in exon 2. 
The MS2 probes labeled a bright spot in the nucleoplasm. This 
spot colocalized with a local accumulation of the large subunit 
of RNA polymerase II (RPB1) and thus corresponded to the JCB • VOLUME 193 • NUMBER 5 • 2011   822
the reverse transcription with oligos specific for uncleaved, 
nascent pre-mRNAs or an oligo-dT primer to detect released, 
polyadenylated  pre-mRNAs  (Fig.  1  E).  The  wild-type  re-
porter showed a single PCR product that corresponded to the 
spliced  RNAs.  This  occurred  for  both  nascent  and  poly-
adenylated mRNAs, demonstrating that splicing of the reporter 
is completed before it is cleaved and polyadenylated (Fig. 1 E).   
3 h after SSA addition, polyadenylated and nascent RNAs 
showed both spliced and unspliced species, and the spliced 
band disappeared after 24 h of treatment. The splice acceptor 
mutant reporter showed predominantly unspliced pre-mRNAs, 
with a minor fraction that was spliced at a cryptic downstream 
site  (unpublished  data). Altogether  these  experiments  firmly 
established that the wild-type reporter was spliced cotranscrip-
tionally, and that this was blocked by the addition of SSA or by 
mutating the 3 splice site.
Recruitment of splicing factors to the 
MINX transcription site
Next, we determined whether splicing factors were recruited 
to  the  MINX  transcription  site  using  two-color  FISH.  In   
untreated cells, all snRNAs were detected at the transcrip-
tion site, but accumulation was weak (Fig. 2 A). In contrast, 
in cells treated with SSA for 3 h, all the snRNA accumulated 
at  the  MINX  transcription  site  at  high  levels  (Fig.  2  B).   
mRNA transcription site (Fig. 1 C). When the three probes were 
used simultaneously, the spliced mRNA showed a signal simi-
lar to that of LacZ, labeling both the cytoplasm and the tran-
scription site, thus suggesting that splicing is cotranscriptional 
(Fig. 1 D and not depicted). To confirm this data, we treated 
cells with spliceostatin A (SSA), a small molecule that inhibits 
splicing (Kaida et al., 2007). 3 h after addition of the drug, the 
spliced probe failed to detect the transcription site, whereas it 
still labeled the cytoplasmic mRNAs that were synthesized be-
fore addition of the drug (Fig. 1 D). Conversely, the signal for 
the intronic MS2 probe that was restricted to the transcription 
site became present throughout the nucleoplasm in a speckled 
pattern, and was even detected in the cytoplasm in a small frac-
tion of the cells.
The results obtained with SSA were confirmed with the 
mutant  reporter  gene  that  lacked  a  functional  3  splice  site   
(Fig. 1 D): the exonic LacZ probes labeled a bright spot in the 
nucleoplasm and showed a diffuse staining in the nucleoplasm 
and the cytoplasm; the intronic MS2 probes labeled the tran-
scription site, the nucleoplasm, and the cytoplasm; and the spliced 
probe did not detect any signal. Altogether, these results demon-
strated that a fraction of the wild-type pre-mRNAs was spliced 
at their transcription site.
We then used an RT-PCR assay to determine the amount of 
pre-mRNA that spliced co- and posttranscriptionally. We primed 
Table I.  Small-scale study of co- and posttranscriptional splicing patterns
Gene Co-transcriptional splicing, 
intron n  1
Size intron Type Cotranscriptional splicing, 
intron n (last)
Size intron Type
bp bp
Constitutive introns 
ILK >90% 112 NA >85% 183 NA
RPL9 >95% 214 NA >80% 307 NA
PSMB6 100% 197 NA 100% 126 NA
UTP15 100% 166 NA >90% 501 NA
ATXN7L3 100% 93 NA >90% 105 NA
EDC4 >85% 390 NA >90% 224 NA
PSENEN 100% 427 NA >75% 184 NA
ALKBH7 ND 88 NA 100% 221 NA
ROGDI 100% 97 NA >85% 212 NA
G6PC3 >90% 222 NA ND NA NA
LASS2 100% 126 NA ND NA NA
TK1 >95% 100 NA ND NA NA
EWSR ND NA NA >80% 3,600 NA
Alternatively spliced 
introns 
ARL6IP 100% 395 Constitutive >90% 82 Intron inclusion (<5%)
SYNGR2 100% 456 Constitutive 100% 90 Intron inclusion (<5%)
FLAD1 85% 2,185 Constitutive >90% 116 Intron inclusion (5%)
ARRDC1 80% 84 Constitutive 70% 74 Intron inclusion (30%)
FAM132B 80% 1,272 Constitutive >95% 66 Intron inclusion (60%)
TUBB2C 100% 82 Constitutive 100% 475 Alternative 5 and 3 
ss (>95%)
CLDN7 ND NA NA <10% 285 Exon cassette (90%)
TUBA1A ND NA NA >90% 621 Exon cassette (>95%)
LMNA >80% 1,256 Exon cassette 
(>95%)
100% 323 Constitutive
Frequences of alternative splicing events in U20S cells are shown in parentheses. NA, not applicable.823 In vivo splicing kinetics • Schmidt et al.
Splicing kinetics and modeling of  
the reaction
The presence of the MS2 tag within the intron allows its vi-
sualization in live cells (Fusco et al., 2003). To determine the 
half-life of the intron, MS2–GFP was bleached at the MINX tran-
scription site (Fig. 3). As the measurements improve when the 
signal of the transcription sites increases over the nucleoplasmic 
background, a nuclear export signal was added to the original 
nuclear MS2–GFPnls protein. This way, the MS2–GFPnls-nes 
displays lower nucleoplasmic signals and allows for a better 
visualization of nuclear RNAs (Fig. 3). Using this technique, 
we measured a half-life of 105 s for the MS2–GFP labeled intron, 
significantly shorter than the 165 s for exon 2.
It was previously demonstrated that the binding of MS2–
GFP to the MS2 stem loops is relatively stable in live cells, as 
little dissociation occurs in the first 10 min of a FRAP experi-
ment. In contrast, diffusion of free MS2–GFP is rapid (Boireau 
et al., 2007). Indeed, recovery of the free pool of MS2–GFP was 
complete 10 s after the bleach, at which time there was no visi-
ble recovery of the transcription sites (Fig. 3 A). Diffusion and 
This suggested that the weak accumulation observed in un-
treated cells was caused by the high efficiency of the splicing 
reaction, as the snRNPs resided only shortly on the pre-mRNA 
to complete splicing. This is consistent with previous studies 
of spliceosome assembly in fixed and live cells, which esti-
mated that spliceosomal components resided on pre-mRNAs 
for 15–30 s on average (Wetterberg et al., 2001; Huranová   
et al., 2010). Interestingly, SF3b155, the known spliceostatin 
target, was also recruited in cells treated with the drug (Fig. 2 D).   
Our data thus suggest that SSA does not block spliceosome 
assembly, but inhibits spliceosome activation, which is in 
agreement with in vitro data (Roybal and Jurica, 2010). We 
next analyzed the splice acceptor mutant. Similar to SSA-
treated cells, we found that all snRNAs were enriched at the 
transcription site of the mutant reporter, including U1 and 
U4 (Fig. 2 C). Altogether, this demonstrated that the spli-
ceosome  was  assembled  cotranscriptionally  on  the  MINX 
reporter, and that SSA and mutating the splice acceptor site 
impaired splicing catalysis but not recruitment of spliceo-
somal components.
Figure 2.  Recruitment of spliceosomal components to the MINX transcription site. (A–C) Recruitment of snRNPs. WT_MS2in and SAmut_MS2in cells were 
transfected with Tat vector and processed for multicolor FISH experiments with probes against LacZ in exon 2 (red), and each of the snRNAs (green).   
In B, cells were treated with SSA. Insets show enlarged views. (D) SF3b155 recruitment in SSA-treated cells. WT_MS2in cells were transfected with vectors 
expressing Tat and MS2–GFP (green), treated with SSA for 3 h, and processed for immunofluorescence against SF3B155 (red). Bars, 10 µm.JCB • VOLUME 193 • NUMBER 5 • 2011   824
Figure 3.  Analysis of splicing kinetics by FRAP. (A) Time series of FRAP experiments. WT_MS2ex2 (top) or WT_MS2in (bottom) cells were transfected with 
vectors expressing Tat and MS2–GFPnsl_nes. Transcription sites were bleached and 3D images were captured for 9–11 min. The time after the bleach 
is indicated in seconds. pre, prebleach image; post, post-bleach image. The arrow points to the transcription site. Bar, 10 µm. (B) FRAP recovery plots. 
Normalized fluorescence intensity at the transcription site is plotted as a function of time (±SEM). Time is in seconds, and the zero time point corresponds 825 In vivo splicing kinetics • Schmidt et al.
to the bleach. (C) Scheme describing the kinetic models. (top) A single step is rate limiting (kspl; red). (bottom) Multiple steps are rate-limiting, all with the 
same rate (kspl; red). (D) Determination of the number of limiting steps. Plot of the AIC values for the optimal choice of the rate of the limiting steps () as a 
function of the number of limiting steps. L is the linear model that was included as a null hypothesis. (E) Optimal fit of the model to the experimental curve. 
The FRAP curve of WT_MS2in cells was fitted with either a single-step model (red), a three-step model (green), or a nine-step model (blue).
 
dissociation of MS2–GFP were thus neglected in the interpreta-
tion of the FRAP curves. Intron turnover included transcription 
from the MS2 repeat to the end of the MINX intron (230 nucle-
otides), splicing, and diffusion and/or degradation of the free 
intron. Given the estimated rates of RNA polymerase II (1.8–4 
kb/min; Boireau et al., 2007; Darzacq et al., 2007; Wada et al., 
2009), transcription to the intron end should take between 3 and 
7.7 s. Furthermore, Northern blots probed with MS2 repeats de-
tected only full-length or nearly full-length mRNAs, rather than 
the free intron (Fig. S1), which indicates that intron degradation 
is rapid and not rate limiting.
Spliceosomes  must  assemble  de  novo  on  each  intron. 
Given the number of components that bind and become assem-
bled into a functional enzyme, this process includes a large num-
ber of elementary steps. Modeling this complicated series of 
events is currently out of reach. Instead, we decided to determine 
the number of steps that are rate-limiting for the reaction by fit-
ting  the  FRAP  curve  with  models  containing  a  single,  two, 
three, and up to nine consecutive limiting steps (Fig. 3 C). If a 
single step in the assembly or catalysis pathway is rate limiting, 
it should impose its kinetic on the whole process, and the FRAP 
curve should adopt a simple exponential shape. In contrast, if 
there are several successive rate-limiting steps, different kinet-
ics will be observed (Fig. 3 E), and this is a key point for alter-
native splicing regulation (see the following paragraph).
We generated a full model that describes transcription and 
splicing, but to fit the data, we derived a simplified model where 
the time for the polymerase to transcribe to the 3 splice site is 
represented by a time offset (), which was constrained to 3–7.7 s   
(Fig. S2). We found a general analytical solution for the simpli-
fied model, and models with 1 and up to 9 limiting steps were 
thus fitted to the FRAP data by finding the optimal values of the 
step rate () and the time offset (; see Materials and methods 
and Fig. S2). Notably, all models have an identical number of 
variables (the step rate, time offset, and a scaling constant), al-
lowing for a fair comparison between them. A linear model was 
also included as a null hypothesis (Fig. S2). The Akaike infor-
mation criterion (AIC) values for the optimal choice of  show 
that the fits improve from one to two limiting steps, is optimal 
for a three step model, and then worsens as the number of steps 
further increases (Fig. 3, D and E). Other indicators of the good-
ness of the fits, such as the distribution of the residuals and the 
reduced 
2 also indicate that the three-step model is the best and 
that models with one step or more than five steps are unlikely 
(Table S1). In addition, the optimal parameters found for the 
three-step model allowed for an accurate description of the FRAP 
curve using the full model (see Fig. S2 for details).
A three-step model indicated a mean splicing time of 162 s 
for MINX. Splicing rates have been analyzed by various methods 
and in several organisms: by EM in Chironomus tentans and 
Drosophila melanogaster (Beyer and Osheim, 1988; Kiseleva 
et al., 1994; Wetterberg et al., 2001), by transcriptional pulse-
chase in mammals (Audibert et al., 2002; Singh and Padgett, 
2009), and by chromatin immunoprecipitation (ChIP) and other 
assays in yeast (Tardiff et al., 2006). Although these methods 
lack the temporal resolution provided by the FRAP assay, the 
estimated splicing rates are in good agreement with our MINX 
data. Indeed, splicing was estimated to occur with a half-time 
of 0.4–7 min in mammalian cells and to be complete in 3 min in 
Drosophila, in 0.5–5 min in C. tentans, and in <1 min in yeast.
Kinetics and noise of splicing
Next, we used values of the best fits to simulate the production 
of the spliced product (Figs. 4 and S2 G). With a single limiting 
step, the appearance of the spliced mRNA follows an exponen-
tial curve. However, with three limiting steps, the appearance of 
the spliced message has a more sigmoidal shape (Fig. 4 A). 
These kinetics can be understood from the viewpoint of a sto-
chastic model. In the case of a single limiting step, some mole-
cules will be spliced quickly, and others slowly, because of the 
stochasticity of the single step. In contrast, if there are several 
successive rate-limiting steps occurring at a similar rate, the sto-
chastic nature of each event will be averaged by the larger num-
ber of steps involved. Each molecule will take a similar time to 
splice, thereby mimicking a deterministic process. Thus, the num-
ber of steps influences the distribution of splicing times around 
the mean. This is confirmed by calculating the probability of 
splicing as a function of time, which shows that the probability 
function peaks more closely around the mean when the number 
of limiting steps increases (Fig. S2 F). To provide a quantitative 
measure of the variation among individual molecules, we defined 
the kinetic noise as the standard deviation of the splicing time, 
for a population of molecules, divided by the mean splicing time. 
The splicing noise is inversely proportional to the root square of 
the number of steps, and thus decreases with additional steps (see 
Materials and methods).
Regulation of alternative splicing
There are many ways to control alternative splicing, but one that 
is particularly relevant here is the so-called “kinetic control,” 
where the time taken to transcribe the DNA between two compet-
ing splice sites creates a delay that favors splicing at the up-
stream site (de la Mata et al., 2003). By inducing polymerase 
pausing or slowing down its elongation rate, it is then possible 
to further increase splicing at the first site. To analyze how the 
kinetic noise impacts this regulation, we considered a hypothet-
ical case of alternative splicing, where a weak acceptor site is in 
competition with a strong downstream site (Fig. 4 A). We assumed 
that splicing occurs at the upstream site only when splicing is 
completed before the polymerase reaches the downstream site, 
and that splicing must switch from 25% at the upstream acceptor 
site to 75%. Using the kinetic parameters of the MINX intron, a JCB • VOLUME 193 • NUMBER 5 • 2011   826
Figure 4.  A three-step model improves the regulation of alternative splicing. (A) A three-step model improves the regulation of cotranscriptional splicing 
events. (A, top) Scheme of a cotranscriptional alternative splicing event regulated by the elongation rate of RNA polymerase II. Splicing occurs at splice   
acceptor SA1 only when the splicing reaction is completed before splice acceptor SA2 is synthesized. When both SA2 and SA1 are present on the 827 In vivo splicing kinetics • Schmidt et al.
pre-mRNA, splicing always occurs at SA2. When the polymerase has a fast elongation rate, 25% of the splicing events take place at site SA1, whereas 
when the polymerase elongates slowly, 75% of the pre-mRNAs are spliced at SA1. (A, bottom) Calculated curves of the appearance of the spliced product 
as a function of time after transcription (seconds), for models having a single (left) or three limiting steps (right), and optimized to fit the MINX kinetics. The 
vertical lines point to the elongation time required to obtain 25% and 75% of splicing at SA1. (B) A three-step model improves the regulation of posttranscrip-
tional splicing events. (B, top) Schematics of a posttranscriptional alternative splicing event. Product A is produced constitutively with n rate-limiting steps, 
whereas product B is produced with a single rate-limiting step that is regulated. (B, bottom) Calculated curves of the appearance of the spliced product A   
as a function of the rate of the competing splicing event B, for models having a single (left) or three limiting steps (right), and optimized to fit the MINX 
kinetics. The vertical lines point to the rates  required to obtain 25% and 75% of product A.
 
one-step model requires a fivefold reduction of the rate of poly-
merase elongation, from 32 to 160 s (Fig. 4 A). In contrast, 
because each molecule is more synchronous in a three-step 
model, a twofold reduction would be sufficient to achieve the 
same effect.
Splicing  regulation  by  elongation  rates  is  only  one  of 
many ways to regulate splicing. Indeed, many splicing events are 
regulated by cis-acting splicing factors (Wahl et al., 2009), and 
alternative splicing regulation can often be reproduced in vitro 
in the absence of transcription. It was therefore of interest to 
compare the impact of the one-step and three-step models on 
the regulation of splicing for cases where splicing regulation 
is disconnected from transcription. For this purpose, we con-
sidered a case of alternative splicing that does not involve tran-
scription (Fig. 4 B). In this model, one splicing event occurs at 
a constitutive rate and leads to product A, whereas a competing 
event B occurs at a rate ; this rate can be regulated, for instance 
by the expression of a key splicing factor (Fig. 4 B). We calcu-
lated the variation of rate  required to shift the production of 
A from 75% to 25%, for the cases where A is made with a one-
step or a three-step model. Again, the three-step model allowed 
for a more efficient splicing regulation, as  has to increase only 
fivefold, compared to nearly tenfold for a single-step model. 
The three-step model also allows for a greater range of splic-
ing regulation. Indeed, having the regulated rate  many times 
greater than the constitutive rate is not plausible in a kinetic 
competition model, and for  ≤ , the production of A can vary 
from 6% to 100% for a three-step model, but remains <50% for 
a one-step model.
Having several limiting steps instead of one thus makes 
the splicing reaction less noisy and allows for a greater and 
more efficient control of alternative splicing, where a small 
change in the rate of a competing process can produce a large 
change in splicing patterns. This is similar to the “molecular 
memory” model previously proposed in a theoretical study of 
transcription and RNA degradation (Pedraza and Paulsson, 
2008). Many RNA maturation steps require the step-wise   
assembly of multicomponent processing machineries. Given 
that nascent pre-mRNAs are present as few molecules per 
cell, a constant time for each of the RNA processing reactions 
may reduce kinetic noise, and facilitate both integration of 
these reactions into an efficient production chain and their 
cross-talk for regulatory events. Many other biological path-
ways deal with few molecules at a time, and our model pro-
vides a general framework to explain how parallel steps in 
such pathways can be kinetically controlled, allowing their 
cross-regulation and their integration in a determined sequence 
of events.
Materials and methods
Cells and plasmids
The constructs were based on the MINX intron (Zillmann et al., 1988), 
which was fused to the LacZ gene and the 3 end processing signals of the 
bovine growth hormone gene (bGH). The MS2 ×4 repeats were inserted 
within the MINX intron (WT_MS2in and SAmut_MS2in) or within exon 2 
(WT_MS2ex2). These plasmids had the backbone of pcDNA3 (Invitro-
gen), but had the cytomegalovirus promoter replaced by the HIV-LTR. Plas-
mids expressing Tat have been described previously (Molle et al., 2009). 
GFP-MS2nsl_nes was created with the Gateway system (Invitrogen).
U2OS cells were cultivated at 37°C in DME (Invitrogen) containing 
10% FCS. Stable clones were generated as described previously (Boireau 
et al., 2007). The copy number of the WT_MS2in reporter gene was 18–20 
copies, as evaluated by quantitative PCR against a cell line having a single 
copy of a LacZ transgene. The number of unspliced MINX pre-mRNA at the 
transcription site (25 ± 10 copies) was measured by single-molecule FISH. 
These relatively large numbers ensure that stochastic variations in transcrip-
tion initiation are averaged and that the system is at steady state. In all ex-
periments, a Tat-expressing plasmid was transfected. Transient transfections 
were performed using Effectene (QIAGEN) and cells were analyzed 16–24 h 
later. For live cell experiments, cells were seeded on glass-bottom dishes 
and analyzed at 37°C in a phenol red and riboflavin-free media, supple-
mented with serum and 20 mM Hepes, pH 7.4. To inhibit splicing, cells 
were treated with 30 ng/ml SSA (Kaida et al., 2007).
In situ hybridization and immunofluorescence
Antibody concentrations were: rabbit anti-RPB1 (Euromedex) 1:3,000; anti–
rabbit FITC 1:1,000 (Jackson ImmunoResearch Laboratories), and anti–rabbit 
Alexa Fluor 647 1:500 (Invitrogen). The anti-SF3b was a gift of R. Lührmann 
(Max-Planck Institute, Göttingen, Germany).
Sequences of the FISH probes were: LacZ-3, 5-AXGAGTTTACGTG-
CAXGGATCTGCAACATGXCCCAGGTGACGATGTAXA-3; LacZ-4, 5-AXC-
GGCAATAATGCCXTTCCATTGTTCAGAAGGCAXCAGTCGGCTTGXA-3;  
LacZ-5, 5-AXTCAGTTCGAGGTGCXGTTTCTGGTCTXCACCCACCGGTA-
CCAGAXA-3; LacZ-6, 5-AXGGGATCGATCXCGCCATACAGCGCGTXG-
AAACGCTGGGCAATATXA-3; LacZ-7, 5-AXGTTGGGTAACGCCAGGG-
XTTTCCCAGTCACGACGXTGTAAAACGAX-3; LacZ-8, 5-AXTCTTCGC-
TATXACGCCAGCTGGCGAAAGGGGGAXGTGCTGCAAGXA-3;  hU1, 
5-AXGGAAAACCACCXTCGTGATCATGGTATCXCCCCTGCCAGGTAAG-
TXA-3; hU2, 5-AXCCATTTAATATATTGTCCTCGGAXAGAGGACGTATCA-
GATATTAAACXA-3; hU4, 5-XXGGGAAAAGTTTXCAATTAGCAATAAXC-
GCGCCTCGGXX-3;  hU5,  5-AXCTTTGATGAAAGGCGAAAGATTTAX-
ACGATCTGAAGAGAAACCAGAGXA-3;  hU6,  5-AXGTCATCCTTGCG-
CAGGGGCCAXGCTAATCTTCTCTGTATCGTTCCAAXA-3; MS2, 5-AXG-
TCGACCTGCAGACAXGGGTGATCCTCAXGTTTTCTAGGCAATXA-3; and   
MINX-spliced, 5-AXCCXCAACCGCGAGCGXTCGGAGGCCGAXA-3.
X designates aminoallyl-modified thymidines, which were coupled 
with Alexa Fluor 488 or 647 (Invitrogen) or Cy3 or Cy5 (GE Healthcare) ac-
cording to the manufacturer’s instructions.
In situ hybridization and immunofluorescence were performed as de-
scribed previously (Schmidt et al., 2006; Boireau et al., 2007). Probes for 
snRNAs and LacZ were hybridized in 40% formamide (Merck), whereas 
oligo-dT and MS2 were hybridized in 20% formamide. FISH of the spliced 
probe was performed in 20% formamide and washed three times in 20% for-
mamide/1× SSC at 65°C, followed by three washes in 1× SSC at 65°C.
Microscopy
Fluorescent images of fixed cells were captured either on a MetaLsm510 
confocal microscope (100×, NA 1.4; Carl Zeiss) or on a DMRA wide-field 
microscope (100×, NA 1.4; Leica), equipped with a CoolSNAP HQ camera 
(Roper Scientific) and controlled by MetaMorph (Universal Imaging). Images 
were prepared with Photoshop (Adobe).JCB • VOLUME 193 • NUMBER 5 • 2011   828
The two alternative approaches give essentially the same result, and 
this is whether they are fitted to FRAP data normalized between 0 and 1, 
or between post-bleach and 1.
To test for the possibility that the exponential models are indistin-
guishable because they give equally poor fits to the data, a linear model 
(SL = mt + c) is included in the analysis as a null hypothesis. We found 
that this case could arise if the data were sufficiently noisy by considering 
synthetic data generated by stochastic simulation. Analysis indicated that 
our modeling and optimization techniques recover the correct number of 
steps (i.e., the number used to generate the data) under conditions similar 
to those of the experimental data, and that under noisier conditions the 
linear model emerges as the best model. Thus, we have confidence that 
the number of steps identified by our method is a realistic reflection of the 
underlying process.
Optimization was performed using the nonlinear least squares (nls) 
package  in  R,  and  models  were  compared  using  the  associated  AIC 
method, which can compute P-values for each model (Burnham and Anderson, 
2002). We also evaluated the goodness of the fits by analyzing the residu-
als and computing the probability that their distribution corresponds to a 
normal function with a Shapiro-Wilk test. Finally, we compared the preci-
sion of the fit to the experimental error using the reduced 
2. All these indi-
cators are given in Table S1 and consistently give a model with three 
limiting steps as the most probable model for splicing. Obtained time con-
stants were then used to calculate the appearance of the spliced product 
over time.
Kinetic noise
Keeping the mean reaction time T constant, the Erlang distribution for an integer 
values of n (the number of steps) gives n/lambda = T (Weber et al., 2005). Then 
the variance is n/lambda
2, or T
2/n, and the kinetic noise is SD/mean = 1/√n.
Co-transcriptional splicing assay
Total  RNA  was  isolated  using  TRIZOL  (Invitrogen)  followed  by  phenol-
chloroform  extraction  and  isopropanol  precipitation  according  to  the 
manufacturer’s instructions. For reverse transcription, 1–5 µg of total RNA 
was  treated  with  RNase-free  DNaseI  (Promega)  and  transcribed  using 
the  Im-PromII  Reverse  Transcription  kit  (Promega)  either  with  a  poly-dT 
primer or a 3 uncleaved primer, hybridizing to the sequence beyond the 
bGH polyA cleavage site. The sequence of the uncleaved primer for the 
MINX reporter was: 5-GAATGACACCTACTCAGA-3. To detect unspliced 
and spliced fragments at the same time, PCR primers binding to exon 1,   
5-TCTAGCAGTGGCGCCGAAC-3, and exon 2, 5-GCAACATGTCCCA-
GGTGACGATGTATTTT-3, were used.
For the endogenous genes of Table I, RT was primed either with 
oligodT or a gene-specific primer hybridizing after the 3 end cleavage 
site, and splicing was assessed using a competitive PCR assay with three 
primers, two that hybridize in the exons flanking the intron, and one that 
binds the intron, as depicted in Fig. 1 A. The size of the “spliced” and 
“unspliced” PCR products was similar to avoid amplification bias. PCR 
reactions were stopped at different cycles, run on gels, and quantified 
after EtBr staining. For alternative splicing events, ratios of isoforms were 
also quantified by PCR using oligo-dT as an RT primer, and the percentage 
of cotranscriptional splicing was normalized to the percentage of intron 
inclusion in polyA mRNAs.
Online supplemental material
Fig. S1 shows Northern blot analysis of cells stably expressing WT_MS2in   
and  SAmut_MS2in  reporter  RNAs.  Fig.  S2  shows  a  model  of  tran-
scription  and  splicing,  and  fits  to  the  experimental  data.  Table  S1 
shows optimal model parameters that fit the experiment intronic FRAP 
curve.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201009012/DC1.
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FRAP was performed on a microscope (TE200; Nikon) with a 100×, 
NA 1.45 objective lens as described previously (Boireau et al., 2007). 
Bleaching time was 1.2 s and recovery was monitored for 11 min with three 
post-bleach durations: 3D stacks were acquired every 3 s over the first 540 s, 
then every 6 s over 60 s, and finally every 12 s for 60 s. Recoveries at the 
transcription sites were then tracked in a small parallelepiped (2 × 2 × 
1.5 µm) placed at the most intense area of the transcription site.
Modeling and optimization
The recovery curves of 34 cells were averaged and were normalized be-
tween 1 and 0 using the prebleached values and the 9-s time point, respec-
tively. The process of transcription and splicing can be modeled with a set 
of differential equations, but to obtain optimal values for the splicing rate 
for a given number of steps, we have used a simplified model where transcrip-
tion from the MS2 site to the 3 splice site is simply described as a time off-
set (Fig. S2). We, however, verified that the optimal parameters obtained 
with the simplified model allowed to correctly simulate the experimental data 
with the full model (Fig. S2). The purpose of the fitting procedure is to de-
termine the number of limiting step of the splicing reaction (n), and the data 
were thus fitted with a series of models corresponding to one and up to 
nine limiting steps of identical rates.
The simplified model is derived as follows. First, n species X1 . . . Xn 
are introduced, such that X1 accumulates at the transcription rate ktx and is 
depleted at the splicing rate , and all other Xi accumulate and deplete at 
rate :
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The model can then be normalized to converge to 1, as t tends to  
by setting ktx = . This model is illustrated in Fig. S2 C. In this way, the model 
and the data are aligned in scale, and we do not need to know ktx in order to 
find the rate  that governs the kinetics of recovery. Strictly speaking, we solve 
for Xn as defined below:
	 X t k X t n n tx n ( ) ( / ) ’ ( ), = ³ a   1	
As each intermediate species contributes equally to the recovered 
signal in proportion to the species concentration, the signal generated by 
n intermediates, Sn(t), is given by the sum of X1 . . . Xn:
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For example, the signal for a process with three intermediates is 
S3(t) = X1/3 + X2/3 + X3/3.
Eq. 1 is optimized to the FRAP data by introducing an offset () to 
account for the delay in the start of recovery caused by the time required to 
transcribe the 3 end of the intron. The optimization parameter k allows for 
uncertainty in the amplitude of the recovery. We optimize S3 as follows:
S3(t)	=	1	–	k[e
(t)	+	2(t		)e
(t)/3	+	
2(t		)
2e
(t)/6].
An alternative technique for optimizing the models is to allow the 
model to converge to a value  other than 1 by fitting:
S3(t)	=		–	e
(t-)		2(t		)e
(t)/3		
2(t		)
2e
(t)/6.
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